American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
ADIAL PHARMACEUTICALS, INC.
$4.7MMarket cap
-$8.0MNet income
6Employees
ADILNASDAQ
2018IPO
About ADIAL PHARMACEUTICALS, INC.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Net income
- -$8.0M
- Total assets
- $6.7M
- Market cap
- $4.7M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $4.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 27, 2018
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review ADIAL PHARMACEUTICALS, INC..
Write a review
Explore
Browse all →
